Literature DB >> 8842442

Effects of protein tyrosine kinase inhibitors on cytokine-induced adhesion molecule expression by human umbilical vein endothelial cells.

M J May1, C P Wheeler-Jones, J D Pearson.   

Abstract

1. Endothelial cells can be stimulated by the pro-inflammatory cytokines interleukin (IL)-1 alpha and tumour necrosis factor (TNF) alpha to express the leukocyte adhesion molecules E-selectin, vascular cell adhesion molecule (VCAM)-1 and intercellular adhesion molecule (ICAM)-1 but the intracellular signalling mechanisms leading to this expression are incompletely understood. We have investigated the role of protein tyrosine kinases (PTK) in adhesion molecule expression by cytokine-activated human umbilical vein endothelial cells (HUVEC) using the PTK inhibitors genistein and herbimycin A, and the protein tyrosine phosphatase (PTP) inhibitor sodium orthovanadate. 2. Maximal E-selectin expression induced by incubation of HUVEC for 4 h with IL-1 alpha (100 u ml-1) and TNF alpha (100 u ml-1) was dose-dependently inhibited by genistein and herbimycin A. Although similar effects were seen on phorbol 12-myristate, 13-acetate (PMA)-induced expression, this was not due to inhibition of protein kinase C (PKC) activity as the selective inhibitors of PKC, bisindolylmaleimide (BIM), Ro31-7549 or Ro31-8220 did not affect IL-1 alpha- or TNF alpha-induced E-selectin expression at concentrations which maximally inhibited PMA-induced expression. 3. Genistein inhibited VCAM-1 expression induced by incubation of HUVEC for 24 h with TNF alpha or IL-1 alpha whereas it did not affect ICAM-1 expression induced by 24 h incubation with either of these cytokines. Herbimycin A inhibited both VCAM-1 and ICAM-1 expression induced by TNF alpha. 4. Basal expression of E-selectin, VCAM-1 and ICAM-1 was dose-dependently enhanced by sodium orthovanadate. In contrast, vanadate differentially affected TNF alpha-induced expression of these molecules with maximal E-selectin and ICAM-1 expression being slightly enhanced and VCAM-1 expression dose-dependently reduced. 5. We also studied the effects of PTK and PTP inhibitors on adhesion of the human pre-myeloid cell line U937 to TNF alpha-stimulated HUVEC. Adhesion of U937 cells to HUVEC pretreated for 4 or 24 h with TNF alpha was dose-dependently inhibited by genistein and herbimycin A but unaffected by daidzein. Adhesion of U937 cells after 4 h was partially inhibited by blocking antibodies against both E-selectin and VCAM-1 but after 24 h was only inhibited by anti-VCAM-1. 6. Sodium orthovanadate had no effect on TNF alpha-induced U937 adhesion but dose-dependently enhanced adhesion to unstimulated HUVEC. Vanadate-induced adhesion was inhibited by an antibody against VCAM-1. 7. These results demonstrate that PTK-mediated phosphorylation events are important for the regulation of adhesion molecule expression by human endothelial cells, and additionally show that PTK inhibitors differentially affect upregulation of different adhesion molecules, implicating divergent regulatory pathways for cytokine-induced adhesion molecule expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842442      PMCID: PMC1909850          DOI: 10.1111/j.1476-5381.1996.tb15602.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  61 in total

Review 1.  Leukocyte-endothelial adhesion molecules.

Authors:  T M Carlos; J M Harlan
Journal:  Blood       Date:  1994-10-01       Impact factor: 22.113

2.  Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway.

Authors:  P Ghersa; R Hooft van Huijsduijnen; J Whelan; Y Cambet; R Pescini; J F DeLamarter
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

Review 3.  Signaling by the cytokine receptor superfamily: JAKs and STATs.

Authors:  J N Ihle; B A Witthuhn; F W Quelle; K Yamamoto; W E Thierfelder; B Kreider; O Silvennoinen
Journal:  Trends Biochem Sci       Date:  1994-05       Impact factor: 13.807

Review 4.  The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction.

Authors:  S Schütze; T Machleidt; M Krönke
Journal:  J Leukoc Biol       Date:  1994-11       Impact factor: 4.962

5.  Tumor necrosis factor-alpha decreases pulmonary artery endothelial nitrovasodilator via protein kinase C.

Authors:  A Johnson; D T Phelps; T J Ferro
Journal:  Am J Physiol       Date:  1994-09

6.  Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells.

Authors:  V W van Hinsbergh; M Vermeer; P Koolwijk; J Grimbergen; T Kooistra
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

7.  cAMP and tumor necrosis factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the endothelial leukocyte adhesion molecule-1 (E-selectin) promoter.

Authors:  L G De Luca; D R Johnson; M Z Whitley; T Collins; J S Pober
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

8.  Tyrosine kinase involvement in IL-1 beta-induced expression of iNOS by beta-cells purified from islets of Langerhans.

Authors:  J A Corbett; G Kwon; T P Misko; C P Rodi; M L McDaniel
Journal:  Am J Physiol       Date:  1994-07

9.  Phosphotyrosine inhibition and control of vascular endothelial cell proliferation by genistein.

Authors:  B M Koroma; E de Juan
Journal:  Biochem Pharmacol       Date:  1994-08-17       Impact factor: 5.858

10.  Genistein enhances the ICAM-mediated adhesion by inducing the expression of ICAM-1 and its counter-receptors.

Authors:  S Tiisala; M L Majuri; O Carpén; R Renkonen
Journal:  Biochem Biophys Res Commun       Date:  1994-08-30       Impact factor: 3.575

View more
  8 in total

1.  Cerebral endothelial activation and signal transduction mechanisms during inflammation and infectious disease.

Authors:  R N Kalaria
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

2.  Selective induction of cell adhesion molecules by proinflammatory mediators in human cardiac microvascular endothelial cells in culture.

Authors:  Jun Yan; Adrian D Nunn; Regi Thomas
Journal:  Int J Clin Exp Med       Date:  2010-10-23

3.  Regulation of adenosine transport by D-glucose in human fetal endothelial cells: involvement of nitric oxide, protein kinase C and mitogen-activated protein kinase.

Authors:  V P Montecinos; C Aguayo; C Flores; A W Wyatt; J D Pearson; G E Mann; L Sobrevia
Journal:  J Physiol       Date:  2000-12-15       Impact factor: 5.182

4.  Diversity through phosphine catalysis identifies octahydro-1,6-naphthyridin-4-ones as activators of endothelium-driven immunity.

Authors:  Daniel Cruz; Zhiming Wang; Jon Kibbie; Robert Modlin; Ohyun Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

5.  Nuclear-localized focal adhesion kinase regulates inflammatory VCAM-1 expression.

Authors:  Ssang-Taek Lim; Nichol L G Miller; Xiao Lei Chen; Isabelle Tancioni; Colin T Walsh; Christine Lawson; Sean Uryu; Sara M Weis; David A Cheresh; David D Schlaepfer
Journal:  J Cell Biol       Date:  2012-06-25       Impact factor: 10.539

6.  Comparative effect of genistein and daidzein on the expression of MCP-1, eNOS, and cell adhesion molecules in TNF-α-stimulated HUVECs.

Authors:  Hye Yeon Cho; Chung Mu Park; Mi Jeong Kim; Radnaabazar Chinzorig; Chung Won Cho; Young Sun Song
Journal:  Nutr Res Pract       Date:  2011-10-28       Impact factor: 1.926

7.  Monocyte adhesion and spreading on human endothelial cells is dependent on Rho-regulated receptor clustering.

Authors:  B Wójciak-Stothard; L Williams; A J Ridley
Journal:  J Cell Biol       Date:  1999-06-14       Impact factor: 10.539

8.  FAK and Pyk2 activity promote TNF-α and IL-1β-mediated pro-inflammatory gene expression and vascular inflammation.

Authors:  James M Murphy; Kyuho Jeong; Yelitza A R Rodriguez; Jung-Hyun Kim; Eun-Young Erin Ahn; Ssang-Taek Steve Lim
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.